● LIVE
Updated 1h ago
· 15 sources tracked
FDA Announces Recall of Common Blood Pressure Medication - Health: Trusted and Empathetic Health and Wellness Information
Inventia Healthcare Limited has voluntarily recalled more than 11,000 bottles of 25-milligram chlorthalidone tablets. The recall stems from a manufacturing issue where tablets may not dissolve properly in the body. This failure to meet dissolution specifications could render the medication ineffective.
What changed
The FDA has issued a recall for over 11,000 bottles of chlorthalidone due to dissolution failures.
Live updates
-
FDA Announces Nationwide Recall of Chlorthalidone Blood Pressure Medication
confidence 100%Inventia Healthcare Limited has voluntarily recalled more than 11,000 bottles of 25-milligram chlorthalidone tablets. The recall stems from a manufacturing issue where tablets may not dissolve properly in the body. This failure to meet dissolution specifications could render the medication ineffective.
What's confirmed:
- Inventia Healthcare Limited voluntarily recalled 25-milligram tablets of chlorthalidone.
- More than 11,000 bottles of the blood pressure medication were recalled nationwide.
- The recall is due to a manufacturing issue where tablets may not dissolve properly.
- The medication failed to meet dissolution specifications.
Still unconfirmed:
- An Indian company is voluntarily recalling the medication.